HS-20094
A Study of HS-20094 in Chinese Adults With Overweight or Obesity
Regeneron · Phase 3 · Completed · Enrollment 604
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| HS-20094 5mg | n/r | n/r | n/r | n/r |
| HS-20094 10mg | n/r | n/r | n/r | n/r |
| HS-20094 15mg | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- HS-20094 5mg: endpoint not reported
- HS-20094 10mg: endpoint not reported
- HS-20094 15mg: endpoint not reported
- Placebo: endpoint not reported